NCT03557242View on ClinicalTrials.gov

Strategies to Prevent Transcatheter Heart Valve Dysfunction in Low Risk Transcatheter Aortic Valve Replacement

NAUnknownINTERVENTIONAL
Enrollment

124

Participants

Timeline

Start Date

July 5, 2018

Primary Completion Date

July 30, 2023

Study Completion Date

July 30, 2023

Conditions
Aortic Stenosis
Interventions
DEVICE

TAVR

Transcatheter Aortic Valve Replacement

OTHER

Warfarin plus Aspirin

Subjects randomized to this arm will receive Warfarin plus aspirin for 30- 45 days post TAVR

OTHER

Aspirin Only

Subjects randomized to this arm will receive aspirin only post TAVR

Trial Locations (7)

11794

Stony Brook Hospital, Stony Brook

20010

Washington Hospital Center, Washington D.C.

23229

Henrico Doctors' Hospital, Richmond

23507

Sentara Norfolk General Hospital, Norfolk

74104

St. John Health System, Tulsa

92121

Foundation for Cardiovascular Medicine, San Diego

07450

The Valley Hospital, Ridgewood

Sponsors
All Listed Sponsors
lead

Medstar Health Research Institute

OTHER